Retinal Arterial Macroaneurysm (RAM)
Definition / Overview
Retinal arterial macroaneurysms are acquired, focal dilations of retinal arterial branches (mostly 2nd-order arterioles), ranging from 100â250 Ξm in diameter. They are classified as hemorrhagic or exudative and most commonly occur along the superotemporal arcade. ICD-10: H35.09.
Key Details
Pathophysiology
Focal embolic damage to arterial walls causes localized ischemia, leading to increased intimal collagen remodeling and vessel permeability. Histopathology shows vessel wall thickening with fibrin and foamy macrophages â changes that mirror age-related arteriosclerosis elsewhere in the body (Fichte et al., 1978). Linear breaks in the arterial wall produce round or fusiform dilation that can rupture, causing hemorrhage and exudation at any retinal level.
Epidemiology
- Incidence: ~1 per 9000 eyes (Beijing Eye Study, Xu et al. 2007)
- Predominantly elderly women
- Hypertension present in 75% of cases â the single strongest association
- 10% bilateral in the hemorrhagic subtype
Classification
- Hemorrhagic RAM: rupture â multilevel hemorrhage (preretinal, intraretinal, subretinal). Better visual prognosis. Can present with sudden vision loss or floaters from vitreous-hemorrhage.
- Exudative RAM: leakage â macular edema, hard exudates. Worse visual prognosis, especially with persistent macular edema.
Diagnosis
- Fundoscopy: out-pocketing of arteriolar wall; may be obscured by hemorrhage/exudation
- fluorescein-angiography: Saccular type fills mid-to-late phase; fusiform type fills early phase. Vessel wall staining Âą late leakage.
- SD-oct-interpretation: quantifies exudation; helpful in exudative type
Diagnostic pearl: Multilevel hemorrhage (simultaneous preretinal + intraretinal + subretinal) is a hallmark of RAM. The only other common causes of this pattern are anemic/leukemic retinopathy and shaken baby syndrome.
Differential Diagnosis
- coats-disease
- von-hippel-lindau
- Secondary RAM from: branch-retinal-vein-occlusion, diabetic-retinopathy, radiation-retinopathy, retinal arteritis
Management
No approved guidelines exist. Approach depends on presentation:
- Observation (first-line): Most macroaneurysms regress spontaneously.
- Systemic workup: Hypertension screening is mandatory in all cases.
- laser-photocoagulation: Moderate-intensity, large-spot (200â500 Ξm), 2â3 rows adjacent to aneurysm. Controversial â risk of BRAO in up to 16% of cases. Reserved for vision-threatening exudation.
- Anti-VEGF (intravitreal-injections): bevacizumab and ranibizumab show promise for macular edema. Pichi et al. (2013) demonstrated reduction in macular edema and hard exudates in all 38 eyes. Not yet extensively studied.
- pneumatic-displacement Âą tPA: for submacular hemorrhage.
- yag-posterior-hyaloidotomy: for premacular hemorrhage â releases trapped blood into vitreous for faster clearance.
Prognosis
- Majority regress spontaneously with good visual outcome
- Hemorrhagic type â better prognosis than exudative (counterintuitive)
- Worst prognosis: persistent macular edema or subretinal hemorrhage
Prevention
Control of hypertension and arteriosclerosis risk factors.
Clinical Relevance
RAM is a high-yield topic for retina exams. The multilevel hemorrhage pattern is a classic exam question. The management controversy (laser vs anti-VEGF vs observation) and the hypertension association make it clinically important. Always investigate for secondary causes (branch-retinal-vein-occlusion, diabetic-retinopathy, radiation-retinopathy) before labeling a macroaneurysm as primary.
Associations
- hypertensive-retinopathy â strongest systemic link
- branch-retinal-vein-occlusion â secondary cause
- diabetic-retinopathy â secondary cause
- radiation-retinopathy â secondary cause
- bevacizumab / ranibizumab â emerging treatment
- fluorescein-angiography â key diagnostic tool
- laser-photocoagulation â traditional treatment (controversial)